You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 21, June 6, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Extract
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Bioterrorism
 •Alert me on articles by topic

Botulinum Toxin in Biowarfare

To the Editor: A historical incident illustrates a number of features of botulinum toxin not discussed in the review of bioweaponry by Dr Arnon and colleagues.1

During World War II, the US Office of Strategic Services (OSS) developed a plan for Chinese prostitutes to assassinate high-ranking Japanese officers with whom they sometimes consorted in occupied Chinese cities. Concealing traditional weapons on the women at the appropriate time would obviously be difficult. Therefore, under the direction of Stanley Lovell, the OSS prepared gelatin capsules "less than the size of the head of a common pin"2 containing a lethal dose of botulinum toxin. Wetted, a capsule could be stuck behind the ear or in scalp hair, later to be detached and slipped into the officer's food or drink. The OSS recognized that the normal background of botulism cases would deflect suspicion from the women.2

The capsules were shipped to Chunking, China. The Navy detachment there, taking nothing for granted, tested the capsules on stray donkeys. The donkeys lived. Lovell was informed that the capsules were faulty, and the project was abandoned. Much later, Lovell learned of the donkey test with, one imagines, some consternation, since "donkeys are one of the few living creatures immune to botulism."2

This incident has been retold in other publications.3-4 No source for the donkey-resistance information is ever given. More recent experience shows that botulism can occur in mules5 and donkeys (R. H. Whitlock, DVM, PhD, written communication, April 27, 2001).

Nevertheless, this incident raises 2 points: (1) botulism need not occur in epidemics when it is being used as a bioweapon, and (2) botulism in animals may be a sign of biowarfare.


AUTHOR INFORMATION

This letter was shown to Dr Arnon, who declined to reply.—ED.

John G. Sotos, MD
Palo Alto, Calif

1. Arnon SS, Schechtler R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285:1059-1070. FREE FULL TEXT
2. Lovell SP. Of Spies & Strategems. Englewood Cliffs, NJ: Prentice-Hall; 1963: 86-88.
3. Moon TN, Eifler CF. The Deadliest Colonel. New York, NY: Vantage Press; 1975: 141-142.
4. Moon T. This Grim and Savage Game: OSS and the Beginning of U.S. Covert Operations in World War II. Los Angeles, Calif: Burning Gate Press; 1991:95-96.
5. Schoenbaum MA, Hall SM, Glock RD, et al. An outbreak of type C botulism in 12 horses and a mule. J Am Vet Med Assoc. 2000;217:365-368, 340. PUBMED

Letters Section Editors: Stephen J. Lurie, MD, PhD, Senior Editor; Jody W. Zylke, MD, Contributing Editor.

JAMA. 2001;285:2716.


RELATED ARTICLE

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management
Stephen S. Arnon, Robert Schechter, Thomas V. Inglesby, Donald A. Henderson, John G. Bartlett, Michael S. Ascher, Edward Eitzen, Anne D. Fine, Jerome Hauer, Marcelle Layton, Scott Lillibridge, Michael T. Osterholm, Tara O'Toole, Gerald Parker, Trish M. Perl, Philip K. Russell, David L. Swerdlow, Kevin Tonat, and for the Working Group on Civilian Biodefense
JAMA. 2001;285(8):1059-1070.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation
Kiraly et al.
Gut 2007;56:1433-1438.
ABSTRACT | FULL TEXT  

The SPINK in chronic pancreatitis: similar finds, different minds
Witt
Gut 2002;50:590-591.
FULL TEXT  

The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease
Threadgold et al.
Gut 2002;50:675-681.
ABSTRACT | FULL TEXT  

Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis
Drenth et al.
Gut 2002;50:687-692.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.